• Richard Freaking Branson and How to be Memorable in Business
    Dec 24 2024

    Three ways to develop a memorable perspective so your peers, employees, clients and new business prospects remember you.

    Show More Show Less
    21 mins
  • Crime Pays. Gaming Sector is Poised for a Breakout Year in 2025, Particularly Take Two.
    Dec 24 2024

    Take Two Interactive is up 13.8% YTD. About half as much as the S&P. But in a year with no blockbuster releases, other than annual franchises like 2K, this is actually a good thing.

    The cyclicality of an industry like gaming can be a double-edged sword, but next year we can use that to our advantage.

    See why $TTWO is poised to breakout in 2025, and what you need to know to feel confident investing in gaming.

    Show More Show Less
    26 mins
  • Omnicom and IPG. What does it mean for the advertising industry. And why Nintendo is the next Disney
    Dec 23 2024

    Two of the world's largest media and advertising holding companies are merging. What does this megamerger mean for the larger advertising and media ecosystem? Is this going to unlock value and drive growth? Or is this a defensive play in order to prevent the house of cards from toppling?

    Nintendo has been a great company for decades, but a relatively unimpressive investment since 2021. Is it time to relook at this stock? Can Nintendo create a larger footprint beyond gaming? Is there an investing thesis to be had?

    Show More Show Less
    25 mins
  • Why 99.9% of Podcasts Suck and Getting in on the GLP-1 Trade...It's Not Too Late
    Dec 23 2024

    There are anywhere between 75,000 and 200,000 business podcasts. Less than .04% of these podcast provide trustworthy information. When you listen to a business podcast, you need to be asking more of your host.

    Four things you should look for in a business podcast.

    And, GLP-1 drugs are now approved for chronic weight management and obesity. This is just the tip of the iceberg though. As GLP-1 indications expand, the opportunity for GLP-1 drugs to transform the healthcare paradigm is both immense and imminent. How can you play this for now and in the future?


    Show More Show Less
    30 mins